Health Information

Prostate-specific antigen (PSA) blood test

Prostate-specific antigen (PSA) blood test


Prostate-specific antigen; Prostate cancer screening test 

Prostate-specific antigen (PSA) is a protein produced by prostate cells.

The PSA test is done to help diagnose and follow prostate cancer in men.

I Would Like to Learn About:

  • How the Test is Performed

    A blood sample is needed.

  • How to Prepare for the Test

    Make sure your health care provider knows all the medicines you are taking. Some drugs cause your PSA level to be falsely low.

    In most cases, no other special steps are needed to prepare for this test.

  • How the Test will Feel

    You may feel slight pain or a prick when the needle is inserted. Afterward, there may be some throbbing or a slight bruise. These soon go away.

  • Why the Test is Performed

    Reasons for a PSA test:

    • This test may be done to screen for prostate cancer.
    • It is also used to follow people after prostate cancer treatment to see if the cancer has come back.
    • If a provider feels the prostate gland is not normal during physical exam.


    Measuring the PSA level can increase the chance of finding prostate cancer when it is very early. But there is debate over the value of the PSA test for detecting prostate cancer. No single answer fits all men.

    Before having the test, talk to your provider about the pros and cons of having a PSA test. Ask about:

    • Whether screening decreases your chance of dying from prostate cancer.
    • Whether there is any harm from prostate cancer screening, such as side-effects from testing or overtreatment of cancer when discovered.

    If you choose to be tested, the PSA is most often done every year to screen men:

    • From ages 55 to 69, if no risk factors are present.
    • Starting around age 40 to 45 if they have a higher chance of developing prostate cancer. A family history of prostate cancer (especially a brother or father) and being African-American are more common risk factors.
  • Normal Results

    The PSA test result cannot diagnose prostate cancer. Only a prostate biopsy can diagnose this cancer.

    Your provider will look at your PSA result and consider your age, ethnicity, medicines you are taking, and other things to decide whether your PSA is normal and whether you need more tests.

    A normal PSA level is considered to be 4.0 ng/mL (nanograms per milliliter of blood).

    • For men in their 50s or younger, a PSA level should be below 2.5 in most cases.
    • Older men often have slightly higher PSA levels than younger men.
  • What Abnormal Results Mean

    A high PSA level has been linked to an increased chance of having prostate cancer.

    PSA testing is an important tool for detecting prostate cancer, but it is not foolproof. Other conditions can cause a rise in PSA, including:

    • A larger prostate
    • Prostate infection (prostatitis)
    • Urinary tract infection
    • Recent tests on your bladder (cystoscopy) or prostate (biopsy)
    • Catheter tube recently placed into your bladder to drain urine
    • Recent intercourse or ejaculation

    Your provider will consider the following things when deciding on the next step:

    • Your age
    • If you had a PSA test in the past and how much and how fast your PSA level has changed
    • If a prostate lump was found during your exam
    • Other symptoms you may have
    • Other risk factors for prostate cancer, such as ethnicity and family history

    Men at high risk may need to have more tests. These may include:

    • Repeating your PSA test, most often sometime within 3 months
    • A prostate biopsy
    • A follow-up test called a free PSA (fPSA). The lower the level of this test, the more likely it is that prostate cancer is present.
    • A urine test called PCA-3

    If you have been treated for prostate cancer, the PSA level can show if treatment is working or if the cancer has come back. Often, PSA level rises before there are any symptoms. This may happen months or years beforehand.

  • Risks

    Slight risks associated with having blood drawn may include:

    • Excessive bleeding
    • Fainting or feeling light-headed
    • Hematoma (blood accumulating under the skin)
    • Infection (a slight risk any time the skin is broken)

Related Information

  Prostate cancerEnlarged prostate...   Prostate brachythe...   Prostate cancerBenign prostatic h...


Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013;190(2):419-426. PMID: 23659877 //www.ncbi.nlm.nih.gov/pubmed/23659877

Getzenberg RH, Partin AW. Prostate cancer tumor markers. In: Wein AJ, Kavoussi LR, Novick AC, et al, eds. Campbell-Walsh Urology. 10th ed. Philadelphia, PA: Elsevier Saunders; 2011:chap 98.

National Cancer Institute. Prostate Cancer Screening. (Health Professional version) April 2, 2015. //www.cancer.gov/cancertopics/pdq/screening/prostate/HealthProfessional/. Accessed April 26, 2015.

U.S. Preventive Services Task Force. Screening for prostate cancer. //www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatefinalrs.htm. Accessed April 20, 2015.


Review Date: 2/2/2015  

Reviewed By: Jennifer Sobol, DO, urologist at the Michigan Institute of Urology, West Bloomfield, MI. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.


A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.